119
Participants
Start Date
December 15, 2019
Primary Completion Date
March 31, 2022
Study Completion Date
March 31, 2022
This is a non-interventional study
N/A. This is a non-interventional study. Following consent, the subject will have biospecimen samples taken during routine standard of care procedures, and provided to Sponsor for analysis. Optional research blood draws may occur at treating physician's discretion to obtain additional tissue samples.
Hospital San Pedro de Alcántare, Cáceres
National Kapodistrian University of Athens, Athens
New York Cancer and Blood Specialists, Port Jefferson Station
Attikon University Hospital, Athens
University Hospital Patras, Pátrai
East Carolina University, Greenville
Mid Florida Hematology and Oncology Center, Orange City
Ocala Oncology Center, Ocala
The Lindner Center for Research and Education at The Christ Hospital -- The Cancer Center, Cincinnati
University Hospital of Ioánnina, Ioannina
Hospital Universitari I Politècnic La Fe, Valencia
University Hospital of Alexandroupolis, Alexandroupoli
Touro Infirmary, New Orleans
Colorado West Healthcare System, dba Grand Valley Oncology, Grand Junction
Utah Cancer Specialists, Salt Lake City
CBCC Global Research, Bakersfield
Pacific Central Coast Health Centers -- SLO Oncology and Hematology Health Center, San Luis Obispo
Northern Light Cancer Care Center, Brewer
National Kapodistrian Hospital/Laikon General Hospital, Athens
Hospital General Universitario de Alicante, Alicante
Lead Sponsor
Notable Labs
INDUSTRY